Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: JSB who wrote (7495)	6/14/1999 2:28:00 PM
From: Dale Baker	Read Replies (1) \| Respond to of 118717

I put on my hip boots last night and waded through BXM's Yahoo thread, not my favorite endeavor. There are two issues - how well is their knee injection selling (30,000 doses or a million sold) and is there inventory piling up on the shelves. This fierce battle will be resolved in the earnings report in July. That's the one thing they seem to agree on. The estimates seem to suggest that sales are going well and will get better. This is basically a fluid you can inject in the knee to relieve arthritis pain instead of using painkillers. Could be a great market for the small majority who benefit from it. I am thinking about dumping IFSX for now and picking up BXM, at least through earnings.